|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
INEGI: Estadísticas a propósito del Día
Mundial contra el Cáncer. http://www.inegi.org.mx/saladeprensa/aproposito/2016/cancer2016_0.pdfAccessed.
March 06–2016
|
|
3
|
Hu B, El Hajj N, Sittler S, Lammert N,
Barnes R and Meloni-Ehrig A: Gastric cancer: Classification,
histology and application of molecular pathology. J Gastrointest
Oncol. 3:251–261. 2012.PubMed/NCBI
|
|
4
|
Lauren P: The two histological main types
of gastric carcinoma: Diffuse and so-called intestinal-type
carcinoma. An attempt at a histo-clinical classification. Acta
Pathol Microbiol Scand. 64:31–49. 1965.PubMed/NCBI
|
|
5
|
Piazuelo MB, Epplein M and Correa P:
Gastric cancer: An infectious disease. Infect Dis Clin North Am.
24:853–869, vii. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tan RYC and Ngeow J: Hereditary diffuse
gastric cancer: What the clinician should know. World J
Gastrointest Oncol. 7:153–160. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fitzgerald RC, Hardwick R, Huntsman D,
Carneiro F, Guilford P, Blair V, Chung DC, Norton J, Ragunath K,
Van Krieken JH, et al: International Gastric Cancer Linkage
Consortium: Hereditary diffuse gastric cancer: updated consensus
guidelines for clinical management and directions for future
research. J Med Genet. 47:436–444. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Corso G, Marrelli D, Pascale V, Vindigni C
and Roviello F: Frequency of CDH1 germline mutations in gastric
carcinoma coming from high- and low-risk areas: Metanalysis and
systematic review of the literature. BMC Cancer. 12:82012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
van der Post RS, Vogelaar IP, Carneiro F,
Guilford P, Huntsman D, Hoogerbrugge N, Caldas C, Schreiber KE,
Hardwick RH, Ausems MG, et al: Hereditary diffuse gastric cancer:
Updated clinical guidelines with an emphasis on germline CDH1
mutation carriers. J Med Genet. 52:361–374. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kakiuchi M, Nishizawa T, Ueda H, Gotoh K,
Tanaka A, Hayashi A, Yamamoto S, Tatsuno K, Katoh H, Watanabe Y, et
al: Recurrent gain-of-function mutations of RHOA in diffuse-type
gastric carcinoma. Nat Genet. 46:583–587. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang K, Yuen ST, Xu J, Lee SP, Yan HH, Shi
ST, Siu HC, Deng S, Chu KM, Law S, et al: Whole-genome sequencing
and comprehensive molecular profiling identify new driver mutations
in gastric cancer. Nat Genet. 46:573–582. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Majewski IJ, Kluijt I, Cats A, Scerri TS,
de Jong D, Kluin RJ, Hansford S, Hogervorst FB, Bosma AJ, Hofland
I, et al: An α-E-catenin (CTNNA1) mutation in hereditary diffuse
gastric cancer. J Pathol. 229:621–629. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gaston D, Hansford S, Oliveira C,
Nightingale M, Pinheiro H, Macgillivray C, Kaurah P, Rideout AL,
Steele P, Soares G, et al: Germline mutations in MAP3K6 are
associated with familial gastric cancer. PLoS Genet.
10:e10046692014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Donner I, Kiviluoto T, Ristimäki A,
Aaltonen LA and Vahteristo P: Exome sequencing reveals three novel
candidate predisposition genes for diffuse gastric cancer. Fam
Cancer. 14:241–246. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li X, Yue ZC, Zhang YY, Bai J, Meng XN,
Geng JS and Fu SB: Elevated serum level and gene polymorphisms of
TGF-beta1 in gastric cancer. J Clin Lab Anal. 22:164–171. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Prasasya RD, Tian D and Kreeger PK:
Analysis of cancer signaling networks by systems biology to develop
therapies. Semin Cancer Biol. 21:200–206. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Munker R and Calin GA: MicroRNA profiling
in cancer. Clin Sci (Lond). 121:141–158. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Volinia S, Calin GA, Liu C-G, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jiang C, Chen X, Alattar M, Wei J and Liu
H: MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis
of gastric cancer. Cancer Gene Ther. 22:291–301. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shrestha S, Hsu SD, Huang WY, Huang HY,
Chen W, Weng SL and Huang HD: A systematic review of microRNA
expression profiling studies in human gastric cancer. Cancer Med.
3:878–888. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ueda T, Volinia S, Okumura H, Shimizu M,
Taccioli C, Rossi S, Alder H, Liu CG, Oue N, Yasui W, et al:
Relation between microRNA expression and progression and prognosis
of gastric cancer: A microRNA expression analysis. Lancet Oncol.
11:136–146. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Song Y, Li J, Zhu Y, Dai Y, Zeng T, Liu L,
Li J, Wang H, Qin Y, Zeng M, et al: MicroRNA-9 promotes tumor
metastasis via repressing E-cadherin in esophageal squamous cell
carcinoma. Oncotarget. 5:11669–11680. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen Y, Kingham K, Ford JM, Rosing J, Van
Dam J, Jeffrey RB, Longacre TA, Chun N, Kurian A and Norton JA: A
prospective study of total gastrectomy for CDH1-positive hereditary
diffuse gastric cancer. Ann Surg Oncol. 18:2594–2598. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sun Y, Shen S, Liu X, Tang H, Wang Z, Yu
Z, Li X and Wu M: miR-429 inhibits cells growth and invasion and
regulates EMT-related marker genes by targeting Onecut2 in
colorectal carcinoma. Mol Cell Biochem. 390:19–30. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wong CM, Wei L, Au SL, Fan DN, Zhou Y,
Tsang FH, Law CT, Lee JM, He X, Shi J, et al: MiR-200b/200c/429
subfamily negatively regulates Rho/ROCK signaling pathway to
suppress hepatocellular carcinoma metastasis. Oncotarget.
6:13658–13670. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
de-Freitas-Junior JC, Carvalho S, Dias AM,
Oliveira P, Cabral J, Seruca R, Oliveira C, Morgado-Díaz JA, Reis
CA and Pinho SS: Insulin/IGF-I signaling pathways enhances tumor
cell invasion through bisecting GlcNAc N-glycans modulation. an
interplay with E-cadherin. PLoS One. 8:e815792013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhu H, Shyh-Chang N, Segrè AV, Shinoda G,
Shah SP, Einhorn WS, Takeuchi A, Engreitz JM, Hagan JP, Kharas MG,
et al: DIAGRAM Consortium; MAGIC Investigators: The Lin28/let-7
axis regulates glucose metabolism. Cell. 147:81–94. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cho MH, Park JH, Choi HJ, Park MK, Won HY,
Park YJ, Lee CH, Oh SH, Song YS, Kim HS, et al: DOT1L cooperates
with the c-Myc-p300 complex to epigenetically derepress CDH1
transcription factors in breast cancer progression. Nat Commun.
6:78212015. View Article : Google Scholar : PubMed/NCBI
|
